TRxADE HEALTH, Inc. (MEDS)
USD 7.59
(4.55%)
USD 7.59
(4.55%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -23.35 USD | -206.03% |
| 2022 | -7.63 USD | -0.66% |
| 2021 | -7.58 USD | -51.9% |
| 2020 | -4.99 USD | -379.81% |
| 2019 | -1.04 USD | -4563.52% |
| 2018 | 0.02 USD | -97.12% |
| 2017 | 0.81 USD | 110.27% |
| 2016 | -7.89 USD | -146.56% |
| 2015 | -3.20 USD | 49.21% |
| 2014 | -6.30 USD | 53.33% |
| 2013 | -13.50 USD | -1291.75% |
| 2012 | -0.97 USD | 0.0% |
| 2008 | -273.59 USD | -101229.63% |
| 2007 | -0.27 USD | -145.45% |
| 2006 | -0.11 USD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | -8.14 USD | 35.24% |
| 2024 Q2 | -1.30 USD | 84.03% |
| 2023 Q4 | -12.57 USD | -175.05% |
| 2023 FY | - USD | -206.03% |
| 2023 Q1 | -0.09 USD | 96.75% |
| 2023 Q2 | -2.90 USD | -3018.28% |
| 2023 Q3 | -4.57 USD | -57.59% |
| 2022 FY | - USD | -0.66% |
| 2022 Q4 | -2.86 USD | -214.29% |
| 2022 Q2 | -1.99 USD | -13.71% |
| 2022 Q3 | -0.91 USD | 54.27% |
| 2022 Q1 | -1.75 USD | -21.53% |
| 2021 Q3 | -2.39 USD | 49.79% |
| 2021 FY | - USD | -51.9% |
| 2021 Q4 | -1.44 USD | 39.75% |
| 2021 Q1 | -1.21 USD | 71.73% |
| 2021 Q2 | -4.76 USD | -293.39% |
| 2020 Q4 | -4.28 USD | -1746.15% |
| 2020 Q2 | -1.07 USD | -374.36% |
| 2020 Q1 | 0.39 USD | 134.21% |
| 2020 Q3 | 0.26 USD | 124.3% |
| 2020 FY | - USD | -379.81% |
| 2019 FY | - USD | -4563.52% |
| 2019 Q4 | -1.14 USD | -1685.54% |
| 2019 Q2 | 0.15 USD | -55.88% |
| 2019 Q1 | 0.34 USD | 169.39% |
| 2019 Q3 | 0.07 USD | -52.07% |
| 2018 Q2 | 0.06 USD | -74.91% |
| 2018 Q1 | 0.23 USD | -41.03% |
| 2018 Q4 | -0.49 USD | -288.46% |
| 2018 Q3 | 0.26 USD | 350.61% |
| 2018 FY | - USD | -97.12% |
| 2017 Q3 | 0.21 USD | 1188.08% |
| 2017 FY | - USD | 110.27% |
| 2017 Q4 | 0.39 USD | 85.71% |
| 2017 Q2 | -0.02 USD | -108.39% |
| 2017 Q1 | 0.23 USD | 118.11% |
| 2016 Q2 | -3.15 USD | -194.39% |
| 2016 FY | - USD | -146.56% |
| 2016 Q3 | -2.41 USD | 23.49% |
| 2016 Q1 | -1.07 USD | 25.17% |
| 2016 Q4 | -1.27 USD | 47.3% |
| 2015 Q3 | -0.36 USD | -125.0% |
| 2015 FY | - USD | 49.21% |
| 2015 Q1 | -1.28 USD | 3.76% |
| 2015 Q2 | -0.16 USD | 87.5% |
| 2015 Q4 | -1.43 USD | -297.22% |
| 2014 Q2 | -0.92 USD | 67.72% |
| 2014 Q3 | -1.07 USD | -16.3% |
| 2014 Q1 | -2.85 USD | 38.18% |
| 2014 Q4 | -1.33 USD | -24.3% |
| 2014 FY | - USD | 53.33% |
| 2013 FY | - USD | -1291.75% |
| 2013 Q3 | -0.93 USD | -34.78% |
| 2013 Q1 | -0.69 USD | 0.0% |
| 2013 Q2 | -0.69 USD | 0.0% |
| 2013 Q4 | -4.61 USD | -395.7% |
| 2012 FY | - USD | 0.0% |
| 2009 Q3 | -0.04 USD | -74.0% |
| 2009 Q1 | -0.11 USD | 99.99% |
| 2009 Q2 | -0.02 USD | 77.27% |
| 2008 Q4 | -1615.77 USD | -4297160.64% |
| 2008 Q2 | -0.06 USD | 8.67% |
| 2008 Q1 | -0.07 USD | 86.35% |
| 2008 FY | - USD | -101229.63% |
| 2008 Q3 | -0.04 USD | 38.46% |
| 2007 Q3 | -0.07 USD | 37.64% |
| 2007 Q2 | -0.11 USD | -1796.55% |
| 2007 Q1 | -0.01 USD | 97.58% |
| 2007 FY | - USD | -145.45% |
| 2007 Q4 | -0.49 USD | -614.29% |
| 2006 Q3 | -0.02 USD | 60.04% |
| 2006 FY | - USD | 0.0% |
| 2006 Q4 | -0.24 USD | -1118.27% |
| 2006 Q2 | -0.05 USD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| CannBioRx Life Sciences Corp. | -52.60 USD | 55.608% |
| BIMI International Medical Inc. | -8.40 USD | -177.976% |
| China Jo-Jo Drugstores, Inc. | -2.93 USD | -696.928% |
| Harrow Health, Inc. 8.625% Senior Notes due 2026 | -0.75 USD | -3013.333% |
| Harrow Health, Inc. 11.875% Senior Notes due 2027 | -0.75 USD | -3013.333% |
| Leafly Holdings, Inc. | -4.74 USD | -392.616% |
| Leafly Holdings, Inc. | -4.74 USD | -392.616% |
| LifeMD, Inc. | -0.70 USD | -3235.714% |
| LifeMD, Inc. | -0.70 USD | -3235.714% |
| PetMed Express, Inc. | -0.37 USD | -6210.811% |
| Walgreens Boots Alliance, Inc. | -10.01 USD | -133.267% |